Cargando…
HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
Hepatic stellate cells (HSCs) are the primary source of matrix components in liver disease such as fibrosis. Phosphatidylinositol 3-kinase (PI3K) signaling in HSCs has been shown to induce fibrogenesis. In this study, we evaluated the anti-fibrotic activity of a novel imidazopyridine analogue (HS-17...
Autores principales: | Son, Mi Kwon, Ryu, Ye-Lim, Jung, Kyung Hee, Lee, Hyunseung, Lee, Hee Seung, Yan, Hong Hua, Park, Heon Joo, Ryu, Ji-Kan, Suh, Jun–Kyu, Hong, Sungwoo, Hong, Soon-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858860/ https://www.ncbi.nlm.nih.gov/pubmed/24326778 http://dx.doi.org/10.1038/srep03470 |
Ejemplares similares
-
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer
por: Rumman, Marufa, et al.
Publicado: (2016) -
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation
por: Kim, Soo Jung, et al.
Publicado: (2014) -
Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
por: Park, Jung Hee, et al.
Publicado: (2017) -
HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy
por: Lee, Ju-Hee, et al.
Publicado: (2014) -
Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/MAPK Pathway of Hepatic Stellate Cells
por: Yoon, Young-Chan, et al.
Publicado: (2020)